We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$9.69B
AUM Growth
+$805M
Cap. Flow
+$420M
Cap. Flow %
4.33%
Top 10 Hldgs %
28.55%
Holding
286
New
47
Increased
108
Reduced
76
Closed
36

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$93.3M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$64.9M
3
AMZN icon
Amazon
AMZN
+$58.3M
4
SYK icon
Stryker
SYK
+$56.3M
5
PRAH
PRA Health Sciences, Inc.
PRAH
+$49.9M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$77M
2
AMGN icon
Amgen
AMGN
+$72.2M
3
AET
Aetna Inc
AET
+$65.7M
4
CELG
Celgene Corp
CELG
+$54.3M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$52.8M

Sector Composition

Rank Sector Weight
1 Financials 21.51%
2 Healthcare 20.26%
3 Technology 19.08%
4 Communication Services 10.55%
5 Industrials 6.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SEM
101
DELISTED
Select Medical
SEM
$31.3M 0.32%
3,292,260
+296,960
+10% +$2.84M
CPA icon
102
Copa Holdings
CPA
$5.56B
$30.8M 0.32%
229,967
-32,009
-12% -$4.16M
JELD icon
103
JELD-WEN Holding
JELD
$94.8M
$30.2M 0.31%
+767,729
New +$28.5M
PYPL icon
104
PayPal
PYPL
$49.5B
$29.9M 0.31%
406,650
-344,913
-46% -$24.9M
PFPT
105
DELISTED
Proofpoint, Inc.
PFPT
$29.4M 0.3%
331,528
-138,235
-29% -$12.5M
MU icon
106
Micron Technology
MU
$1.04T
$29M 0.3%
705,223
+397,057
+129% +$17.1M
PTLA
107
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$28.6M 0.3%
588,200
– –
IPG
108
DELISTED
Interpublic Group of Companies
IPG
$28.6M 0.29%
1,416,216
-85,488
-6% -$1.7M
STE icon
109
Steris
STE
$20.9B
$28.5M 0.29%
326,384
+40,000
+14% +$3.57M
EVBG
110
DELISTED
Everbridge, Inc. Common Stock
EVBG
$28M 0.29%
941,221
-20,755
-2% -$566K
ICUI icon
111
ICU Medical
ICUI
$3.93B
$27M 0.28%
125,006
– –
RNG icon
112
RingCentral
RNG
$4.05B
$26.6M 0.27%
549,569
-68,681
-11% -$3.13M
OMCL icon
113
Omnicell
OMCL
$1.86B
$26.2M 0.27%
540,938
+97,457
+22% +$4.92M
FIVN icon
114
FIVE9
FIVN
$1.77B
$26.1M 0.27%
1,049,247
-138,926
-12% -$3.43M
TDOC icon
115
Teladoc Health
TDOC
$1.58B
$25.7M 0.26%
736,446
+124,946
+20% +$4.15M
CCL icon
116
Carnival Corporation Ltd
CCL
$36.1B
$25.6M 0.26%
385,020
-1,054
-0.3% -$69.8K
CLDR
117
DELISTED
Cloudera, Inc.
CLDR
$25.4M 0.26%
1,537,115
+635,600
+71% +$10.2M
TXN icon
118
Texas Instruments
TXN
$255B
$25.1M 0.26%
239,857
-65,359
-21% -$6.36M
ANET icon
119
Arista Networks
ANET
$219B
$25M 0.26%
1,695,360
-1,454,640
-46% -$19.5M
MDSO
120
DELISTED
Medidata Solutions, Inc.
MDSO
$24.9M 0.26%
392,851
+130,625
+50% +$9.31M
EA icon
121
Electronic Arts
EA
$52.4B
$24.3M 0.25%
231,625
-35,843
-13% -$3.98M
PEGA icon
122
Pegasystems
PEGA
$4.41B
$24.1M 0.25%
1,022,254
+260,882
+34% +$7M
CELG
123
DELISTED
Celgene Corp
CELG
$23.5M 0.24%
225,000
-481,541
-68% -$54.3M
HRTG icon
124
Heritage Insurance Holdings
HRTG
$842M
$23.4M 0.24%
1,300,000
– –
BMRN icon
125
BioMarin Pharmaceuticals
BMRN
$11.5B
$22.7M 0.23%
254,800
-11,911
-4% -$1.04M
3 4
5
6 7

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Polar Capital held 286 positions worth $9.69B, up 9.1% from $8.89B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Polar Capital deployed $420M of net new capital in Q4 2017, opening 47 new positions and adding to 108 existing holdings. Its largest new stake was Alnylam Pharmaceuticals: 516,232 shares worth $65.6M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Aetna Inc, an estimated $65.7M trimmed.

  • Polar Capital's largest Q4 2017 buy was Alnylam Pharmaceuticals: 516,232 shares worth $65.6M.
  • Polar Capital added most to Microsoft in Q4 2017, an estimated $93.3M increase.
  • Polar Capital's biggest Q4 2017 reduction was Aetna Inc, cutting an estimated $65.7M.
  • Polar Capital fully exited PepsiCo in Q4 2017, selling an estimated $77M.
  • Polar Capital's ten largest holdings make up 29% of its $9.69B portfolio in Q4 2017.
  • Polar Capital opened 47 new positions and closed 36 in Q4 2017.
  • Polar Capital's portfolio value rose 9.1% quarter-over-quarter to $9.69B.

Based on Polar Capital's 13F filing for Q4 2017, filed 14 Feb 2018.